B-type natriuretic peptide (BNP) and its precursor, NT-proBNP, are biomarkers that indicate heart failure. Elevated levels of BNP are associated with increased cardiac pressure and volume overload. In epidemiology, BNP is used to study the prevalence of heart failure and to evaluate the effectiveness of treatment protocols.